Study Details
Testing a Study Drug Efgartigimod for Adults with Bullous Pemphigoid
(IRB#: IRB_00154051)
Bullous Pemphigoid is a painful blistering disease. This study will test Efgartigimod to treat adults and adolescents with this disease. The study will see if the drug will help people with the disease and is safe. People in the study will be randomly chosen to be treated with efgartigimod or a placebo. The placebo looks like the drug but does not have the medication. The drug and placebo are taken as subcutaneous injections. Being in the study requires multiple ways of participation such as completing a study diary and attending in person at a study clinic for about 2 years. Medical tests will be done during the study to track the health of participants.
- All genders
- Over 18 years old
- Volunteers with special conditions
- In Person
- Paid
Who can participate?
Gender: All genders
Age: Over 18 years old
Volunteers: Volunteers with special conditions
Location: In Person
Inclusion Criteria
- Diagnosis of Bullous Pemphigoid
- Access to internet
- Access to phone or video calls
- Able to write in a journal daily
- Able to attend in person at a study clinic
Exclusion Criteria
- Participation in any other study
- Planned surgery
- Pregnant
- Sudden new health problems
- Admitted to a hospital or are going for treatment
Will I be paid for my time?
Yes
IRB#: IRB_00154051
PI: Jamie Rhoads
Department: DERMATOLOGY
Approval Date: 2023-01-18 07:00:00
Specialties: Dermatology